Hygiene Clinical Trial
Official title:
Single Center, Open, Cross-over, Phase III Study for Comparative Evaluation of Safety Use and Efficacy in the Odor Reduce and Vaginal Moisturize Increase for Intimates Use Products Dermacyd Femina Delicata, Dermacyd Femina Breeze, Dermacyd Teen Sweet Flower, Dermacyd Teen Fresh Mix and Dermacyd Femina Comparing to the Control Product Glycerine Vegetal Soap Granado Traditional.
Verified date | January 2011 |
Source | Sanofi |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Interventional |
Primary Objective:
- To prove the efficacy superiority in reducing the genital odor and increase hydration in
mucosa genital comparing the use of Dermacyd (different fragrances) and Glycerine Vegetal
Soap Granado Traditional
Secondary Objective:
- To evaluate the safety in normal conditions of use, verifying clinical signs and lab
exams.
Status | Completed |
Enrollment | 230 |
Est. completion date | December 2010 |
Est. primary completion date | December 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion criteria: - Perfect mucosa in the product analysis region - Volunteers with active sexual life: normal Papanicolau test performed less than one year is mandatory - Bacterioscopy describing the vaginal flora - Negative Trichomonas vaginalis test - Negative Whiff test - Willingness in using preservative in the sexual intercourse during the study period - Use the same category cosmetics products - Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion Exclusion criteria: - Use of antiinflammatory / immunosuppression / antihistaminic drugs - Atopic or allergy history to cosmetic products - Active cutaneous disease (local and/or disseminated) in the evaluated area - Disease which can cause immunosuppression, such as diabetes, HIV, etc. - Endocrine pathology such as thyroid disease, ovarian or adrenal gland disturbs - Intense solar exposure (to get a tan) during the 15 days before the evaluation - Gynecologic treatment until four weeks before the evaluation - Any vaginal infection detected during the inclusion - Other conditions considered by the investigator as reasonable for exclude the patient in the study. The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial. |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Brazil | Sanofi-Aventis Investigational Site Number 076-001 | Osasco |
Lead Sponsor | Collaborator |
---|---|
Sanofi |
Brazil,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Reduction of genital odor and increase hydration in genital mucosa | Patient's questionnaire will be completed at V1, V2 and V4. Reduction of vaginal odor, increase in the moisture area, and perception about some items like foam, facility of rinsing, final touch of the mucosa, final fragrance, and cleaning sensation will be rated on a 5-point scale. | From the treatment start to the end of the study (day 67) | No |
Secondary | Evaluation of the integrity of the mucosa | Onset of erythema, edema, scaling, blisters or other clinical sign will be evaluated. | From the treatment start to the end of the study (day 67) | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02342860 -
The Impact of Improved WASH in Schools on Absence, Diarrhea and Helminth Infection in Lao PDR
|
N/A | |
Completed |
NCT00783939 -
Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.
|
Phase 3 | |
Completed |
NCT00784121 -
Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility
|
Phase 3 | |
Completed |
NCT00784069 -
Dermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation
|
Phase 3 | |
Completed |
NCT00783640 -
Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation
|
Phase 3 | |
Completed |
NCT00783861 -
Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility
|
Phase 3 | |
Completed |
NCT00793026 -
Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability
|
Phase 3 | |
Completed |
NCT00794612 -
Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.
|
Phase 3 | |
Completed |
NCT04382690 -
Behavioral Determinants That May Influence People's Hand-hygiene and Environment Disinfecting
|
||
Completed |
NCT00761800 -
Dermacyd Teen Care Tangerina Mix - Compatibility
|
Phase 3 | |
Completed |
NCT00497783 -
Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)
|
Phase 4 | |
Completed |
NCT00497692 -
Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)
|
Phase 4 | |
Completed |
NCT00371852 -
Topic Compatibility Dermacyd Wipes - Lactoserum - Hygiene
|
Phase 3 | |
Completed |
NCT00380991 -
Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene
|
Phase 3 | |
Completed |
NCT03032887 -
Reducing Visitors- and Personnel-associated Infection Risk on Perinatal Care Station
|
N/A | |
Completed |
NCT00881270 -
Dermacyd Infantile - Acceptability.
|
Phase 4 | |
Completed |
NCT00679562 -
Lactacyd Radiance (Lactic Acid) Prophetic Patch Test
|
Phase 2 | |
Completed |
NCT00933699 -
Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.
|
Phase 3 | |
Completed |
NCT00932945 -
Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal
|
Phase 3 | |
Completed |
NCT00933504 -
Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral
|
Phase 3 |